KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Raw Materials (2018 - 2025)

Globus Medical (GMED) has disclosed Raw Materials for 8 consecutive years, with $152.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Raw Materials rose 31.33% year-over-year to $152.1 million, compared with a TTM value of $152.1 million through Sep 2025, up 31.33%, and an annual FY2024 reading of $122.0 million, up 18.03% over the prior year.
  • Raw Materials was $152.1 million for Q3 2025 at Globus Medical, down from $153.3 million in the prior quarter.
  • Across five years, Raw Materials topped out at $153.3 million in Q2 2025 and bottomed at $41.7 million in Q1 2021.
  • Average Raw Materials over 5 years is $84.8 million, with a median of $75.0 million recorded in 2023.
  • The sharpest move saw Raw Materials rose 5.48% in 2021, then soared 71.32% in 2023.
  • Year by year, Raw Materials stood at $41.8 million in 2021, then skyrocketed by 44.25% to $60.3 million in 2022, then skyrocketed by 71.32% to $103.3 million in 2023, then grew by 18.03% to $122.0 million in 2024, then grew by 24.71% to $152.1 million in 2025.
  • Business Quant data shows Raw Materials for GMED at $152.1 million in Q3 2025, $153.3 million in Q2 2025, and $118.6 million in Q1 2025.